Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer

With proven efficacy of the use of immunotherapy in almost all stages of NSCLC, immunotherapy toxicity has become a very important topic that requires immediate recognition and management. The diagnosis of toxicities associated with immunotherapy in lung cancer can be very challenging and often requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Michael, Rashdan, Sawsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514873/
https://www.ncbi.nlm.nih.gov/pubmed/34660286
http://dx.doi.org/10.3389/fonc.2021.720759
_version_ 1784583491024846848
author Burke, Michael
Rashdan, Sawsan
author_facet Burke, Michael
Rashdan, Sawsan
author_sort Burke, Michael
collection PubMed
description With proven efficacy of the use of immunotherapy in almost all stages of NSCLC, immunotherapy toxicity has become a very important topic that requires immediate recognition and management. The diagnosis of toxicities associated with immunotherapy in lung cancer can be very challenging and often requires multidisciplinary effort. This mini review gives an overview of the diagnosis and management of immune-related adverse events that arise from using immunotherapy in NSCLC, as well as the potential biomarkers for its early identification and future directions.
format Online
Article
Text
id pubmed-8514873
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85148732021-10-15 Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Burke, Michael Rashdan, Sawsan Front Oncol Oncology With proven efficacy of the use of immunotherapy in almost all stages of NSCLC, immunotherapy toxicity has become a very important topic that requires immediate recognition and management. The diagnosis of toxicities associated with immunotherapy in lung cancer can be very challenging and often requires multidisciplinary effort. This mini review gives an overview of the diagnosis and management of immune-related adverse events that arise from using immunotherapy in NSCLC, as well as the potential biomarkers for its early identification and future directions. Frontiers Media S.A. 2021-09-30 /pmc/articles/PMC8514873/ /pubmed/34660286 http://dx.doi.org/10.3389/fonc.2021.720759 Text en Copyright © 2021 Burke and Rashdan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Burke, Michael
Rashdan, Sawsan
Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title_full Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title_fullStr Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title_full_unstemmed Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title_short Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
title_sort management of immune-related adverse events in patients with non-small cell lung cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514873/
https://www.ncbi.nlm.nih.gov/pubmed/34660286
http://dx.doi.org/10.3389/fonc.2021.720759
work_keys_str_mv AT burkemichael managementofimmunerelatedadverseeventsinpatientswithnonsmallcelllungcancer
AT rashdansawsan managementofimmunerelatedadverseeventsinpatientswithnonsmallcelllungcancer

Ejemplares similares